Identification of Determinants Required for Agonistic and Inverse Agonistic Ligand Properties at the ADP Receptor P2Y12

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Pharmacology

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.112.082198PMID 23093496PMCID PMC3533468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ligand specificity of the G-protein-coupled receptor GPR34.

  2012cited by this paper
• Identification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system

  2012cited by this paper
• Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling

  2011cited by this paper
• Interactions between clopidogrel and proton pump inhibitors: a review of evidence.

  2011cited by this paper
• P2Y12 receptor gene mutation associated with postoperative hemorrhage in a Greater Swiss Mountain dog.

  2011cited by this paper
• Ticagrelor: a novel reversible oral antiplatelet agent.

  2011cited by this paper
• Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors

  2011cited by this paper
• ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules.

  2011cited by this paper
• Bcl::Cluster: A method for clustering biological molecules coupled with visualization in the Pymol Molecular Graphics System

  2011cited by this paper
• Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor

  2011cited by this paper
• Deconvolution of complex G protein–coupled receptor signaling in live cells using dynamic mass redistribution measurements

  2010influential reference
• Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor

  2009cited by this paper
• Haploinsufficiency of the platelet P2Y12 gene in a family with congenital bleeding diathesis

  2009cited by this paper
• Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study.

  2009cited by this paper
• RosettaLigand docking with full ligand and receptor flexibility.

  2009cited by this paper
• Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor.

  2008cited by this paper
• The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 Receptor*

  2008cited by this paper
• Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors

  2008cited by this paper
• Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.

  2008influential reference
• A Melanocortin 1 Receptor Allele Suggests Varying Pigmentation Among Neanderthals

  2007cited by this paper
• Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis

  2007cited by this paper
• Rapid identification of functionally critical amino acids in a G protein–coupled receptor

  2007cited by this paper
• Clustal W and Clustal X version 2.0

  2007cited by this paper
• From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

  2007influential reference
• ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibility

  2006cited by this paper
• The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts.

  2006cited by this paper
• Identification of a Potent Inverse Agonist at a Constitutively Active Mutant of Human P2Y12 Receptor

  2005influential reference
• Techniques: promiscuous Galpha proteins in basic research and drug discovery.

  2005influential reference
• The P2 Receptors and Congenital Platelet Function Defects

  2005cited by this paper
• Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon

  2005cited by this paper
• Multipass membrane protein structure prediction using Rosetta

  2005cited by this paper
• Delineation of ligand binding and receptor signaling activities of purified P2Y receptors reconstituted with heterotrimeric G proteins

  2004cited by this paper
• Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae.

  2004cited by this paper
• N‐linked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expression

  2004cited by this paper
• Purification and functional reconstitution of the human P2Y12 receptor.

  2003cited by this paper
• The Structural Evolution of a P2Y-like G-protein-coupled Receptor*

  2003influential reference
• 2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12.

  2003cited by this paper
• Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding

  2003cited by this paper
• Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.

  2003cited by this paper
• Characterization and Channel Coupling of the P2Y12Nucleotide Receptor of Brain Capillary Endothelial Cells*

  2002influential reference
• Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors

  2002cited by this paper
• P2y(12), a new platelet ADP receptor, target of clopidogrel.

  2001cited by this paper
• Identification of the platelet ADP receptor targeted by antithrombotic drugs

  2001cited by this paper
• An elusive receptor is finally caught: P2Y(12'), an important drug target in platelets.

  2001cited by this paper
• ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999*

  2001influential reference
• Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists.

  2001cited by this paper
• The PSIPRED protein structure prediction server

  2000cited by this paper
• Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase.

  1999cited by this paper
• Direct Demonstration of Mechanically Induced Release of Cellular UTP and Its Implication for Uridine Nucleotide Receptor Activation*

  1997cited by this paper
• Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.

  1994cited by this paper
• Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.

  1994cited by this paper
• Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.

  1994cited by this paper
• Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.

  1983influential reference
• Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha- granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor

  1979cited by this paper
• Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor.

  1979cited by this paper
• Muscarinic acetylcholine receptor.

  1978cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper

• The repertoire and structure of adhesion GPCR transcript variants assembled from publicly available deep-sequenced human samples

  2024cites this paper
• Pilocarpine-induced acute seizure causes rapid area-specific astrogliosis and alters purinergic signaling in rat hippocampus.

  2023cites this paper
• Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformation.

  2022cites this paper
• Ginsenoside Rg5 allosterically interacts with P2RY12 and ameliorates deep venous thrombosis by counteracting neutrophil NETosis and inflammatory response

  2022cites this paper
• Venovenous extracorporeal CO2 removal to support ultraprotective ventilation in moderate-severe acute respiratory distress syndrome: A systematic review and meta-analysis of the literature

  2022cites this paper
• The Antiplatelet Effect and Chemical Activity of N6-Chloroadenosine Phosphate

  2021cites this paper
• Venovenous Extracorporeal CO2 removal to support ultraprotective ventilation in moderate-severe ARDS: A systematic review and meta-analysis of the literature

  2021cites this paper
• Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor

  2021cites this paper
• A Study on Anti-Oxidant, Anti-Bacterial, Antifungal, And Anti Platelet Aggregation Potential and Characterization of Ethanolic Extract of Citrus limon (L) Burm. f. Rutacae Peel from

  2021cites this paper
• NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis.

  2021cites this paper
• Molecular Pharmacology of P2Y Receptor Subtypes.

  2020cites this paper
• Update of P2Y receptor pharmacology: IUPHAR Review 27

  2020cites this paper
• Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches

  2020cites this paper
• Pharmacology of P2Y receptors.

  2019cites this paper
• Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.

  2018cites this paper
• Thrombosis and Embolism: from Research to Clinical Practice

  2017cites this paper
• Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6

  2017cites this paper
• P2Y Receptors in Immune Response and Inflammation.

  2017cites this paper
• Structure, Pharmacology and Roles in Physiology of the P2Y12 Receptor.

  2017cites this paper
• Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus

  2017cites this paper
• Pharmacology and structure of P2Y receptors.

  2016cites this paper
• Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.

  2016cites this paper
• Role of P2Y12 Receptor in Thrombosis.

  2016cites this paper
• Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling.

  2016cites this paper
• GPCR crystal structures: Medicinal chemistry in the pocket.

  2015cites this paper
• Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation.

  2015cites this paper
• Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information

  2015cites this paper
• Nucleotides Acting at P 2 Y Receptors : Connecting Structure and Function

  2015cites this paper
• MOL095711 220..230

  2015cites this paper
• Rare platelet GPCR variants: what can we learn?

  2015cites this paper
• Nucleotides Acting at P2Y Receptors: Connecting Structure and Function

  2015cites this paper
• Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.

  2015cites this paper
• John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors☆

  2014cites this paper
• Agonist-bound structure of the human P2Y12 receptor

  2014cites this paper
• A novel mutation in the P2Y12 receptor and a function‐reducing polymorphism in protease‐activated receptor 1 in a patient with chronic bleeding

  2014cites this paper